Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,7611,780 of 20,252 grants

Active NON-SBIR/STTR RPGS
PPARD hyperactivation promotes pancreatic intraepithelial neoplasia progression into pancreatic ductal adenocarcinoma
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

Pancreatic ductal adenocarcinoma (PDA) incidence is rising. Pancreatic intraepithelial neoplasms (PanINs) are PDA precursors that are common in asymptomatic adults, but only few pr...

$6.66M
USD
Active NON-SBIR/STTR RPGS
Tumor-activatable Interleukin-2 Superkine Nanoparticle Therapy
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2024 – 2029

Abstract Interleukin-2 (IL-2) is an immunostimulatory cytokine that plays a central role in antitumor immunity, particularly in the activation and proliferation of T cells and natu...

$3.99M
USD
Completed NON-SBIR/STTR RPGS
Exploring new strategy for breast cancer immunoprevention by targeting histamine receptor H1
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2026

Project Summary/Abstract New strategies to prevent breast cancer are urgently needed because: i) breast cancer incidence rates keep rising by 0.5% per year and about 13%, or 1 in 8...

$2.27M
USD
Active OTHER RESEARCH-RELATED
Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN)
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2027

ABSTRACT Leveraging decades of NCI investments in clinical trials, data infrastructure, and cancer screening research, the I-SCREEN (Improving Strategies for Cancer Reduction throu...

$9.3M
USD
Active OTHER RESEARCH-RELATED
Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub)
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2027

PROJECT SUMMARY New cancer screening technologies with great promise for reducing cancer death are emerging. These technologies require large-scale, controlled clinical trials to e...

$8.64M
USD
Active OTHER RESEARCH-RELATED
Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2024 – 2027

Project Summary/Abstract. The overarching goal for the Stephenson Cancer Center (SCC) Oklahoma Tribal, Rural, Urban Cancer Screening Trial (OK TRUST) ACCESS Hub is to enhance capac...

$8.06M
USD
Active NON-SBIR/STTR RPGS
Computational and functional discovery of isoforms driving cancer and drug resistance
NATIONAL CANCER INSTITUTE University of California Santa Cruz United States 2024 – 2029

ABSTRACT A major challenge for the cancer genomics community is determining which somatic mutations are contributing to tumorigenesis, which are “passenger” (neutral) mutations, an...

$6.98M
USD
Active NON-SBIR/STTR RPGS
Project 2
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2029

Project Summary Survival for breast, prostate and colorectal cancer has improved dramatically over the past three decades as a result of advances in treatment and screening for the...

Active NON-SBIR/STTR RPGS
Genetic Variation in Cancer Risk and Outcomes in African Americans
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2029

African Americans experience higher cancer incidence and mortality rates, are diagnosed at more advanced stages, and have poorer overall survival than other populations. They are a...

Active NON-SBIR/STTR RPGS
Admin Core
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2029

Project Summary The Program entitled “Genetic Variation in Cancer Risk and Outcomes in African Americans” comprises three Research Projects and two Shared Resource Core components...

Active NON-SBIR/STTR RPGS
Core 1
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2029

PROJECT SUMMARY—Data Collection and Clinical Genetics Core The Program entitled “Genetic Variation in Cancer Risk and Outcomes in African Americans” comprises three Research Projec...

Active OTHER RESEARCH-RELATED
Validation of Quality Measures for Patient-Centered Cancer Communication in Rwanda
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT The burden of cancer is rising in Africa and mortality rates are high. A majority (70-80%) of patients present at advanced stages, and cancer care incurs s...

$2.7M
USD
Active NON-SBIR/STTR RPGS
Genetic Variation in Cancer Risk and Outcomes in African Americans
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2029

Project Summary/Abstract—Overall Program Genetic testing for both germline and somatic mutations has improved our understanding of the basic biology of carcinogenesis, identified h...

$19.2M
USD
Active NON-SBIR/STTR RPGS
Project 1
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2029

Project Summary Understanding the spectrum of germline mutations underlying hereditary cancers has clear clinical implications, and while mutations in at least four dozen genes hav...

Active OTHER RESEARCH-RELATED
Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN)
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2027

Multi-cancer detection assays offer new opportunities to screen for many different cancers that currently have limited options for early detection. The Cancer Screening Research Ne...

$15.19M
USD
Active NON-SBIR/STTR RPGS
A Real-Time AI-Driven High-Throughput Proteomics Data Acquisition Method for Clinical Applications
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2027

SUMMARY Cancer is caused by dynamics of the genome, which ultimately translate into aberrations of the proteome constituting the major functional and structural components of a cel...

$2.34M
USD
Completed SBIR-STTR RPGS
Development of Heterobivalent Small-Molecule Therapeutics for the Treatment of Triple-Negative Breast Cancer
NATIONAL CANCER INSTITUTE Weatherwax Biotechnologies Corporation United States 2024 – 2025

ABSTRACT Breast cancer is the most prevalent cancer in women and the second leading cause of cancer related death. Approximately 20% of breast cancer cases are triple negative brea...

$2.96M
USD
Completed OTHER RESEARCH-RELATED
Explainable Artificial Intelligence for Melanoma Recurrence Prediction via Integrative Modeling of Multiplexed Imaging with Transcriptomics and Histopathology
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2026

ABSTRACT Recurrence from early-stage (stage I/II) primary melanomas, often undetected until symptomatic metastasis, accounts for most melanoma mortality. Current prognostic tools a...

$1.76M
USD
Active OTHER RESEARCH-RELATED
NCI Cancer Screening Research Network: Coordinating and Communication Center
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2027

SUMMARY/ABSTRACT The promise of early detection to reduce the burden of cancer is an easily understood and highly desired intervention point in the cancer continuum. Recent develop...

$11.3M
USD
Completed NON-SBIR/STTR RPGS
Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIV
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2024

PROJECT ABSTRACT Tobacco use has alarmingly high rates among people with HIV (PWH), 43% compared with 15% in the general population. Due to the development of highly effective trea...

$10
USD